mhra

1 stories · following the connections

Business

XOMA Announces Significant Step Toward Initiating Pediatric Phase 2 Clinical Study for XOMA 358 in Children with Congenital Hyperinsulinism

By Nasdaq OMXOct 19, 2016, 1:01 PM UTC